Pigmented Episcleral Deposits after Brachytherapy of Uveal Melanoma

Ophthalmology

Volumn 113, Issue 5, 2006, Pages 865-873

  Toivonen, Päivi ^a   Kivelä, Tero ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; RUTHENIUM;

ADOLESCENT; ADULT; AGED; ARGON PLASMA COAGULATION; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CILIARY BODY TUMOR; CLINICAL TRIAL; COLOR; CONFIDENCE INTERVAL; ENUCLEATION; FEMALE; HEIGHT; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SCLERA DISEASE; SLIT LAMP; THICKNESS; TUMOR VOLUME; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATROPHY; BRACHYTHERAPY; CHOROID; FEMALE; HUMANS; IODINE RADIOISOTOPES; MACROPHAGES; MALE; MELANOMA; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; PIGMENTATION DISORDERS; PROSPECTIVE STUDIES; RADIATION INJURIES; RUTHENIUM RADIOISOTOPES; SCLERAL DISEASES; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 33646147361     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2005.10.059     Document Type: Article

References (29)

1. Boniuk M., and Hawkins W.R. Transscleral migration of pigment following cryotherapy of intraocular glioma. Trans Am Acad Ophthalmol Otolaryngol 75 (1971) 60-69
2. Liszauer A.D., Brownstein S., Corriveau C., and Deschenes J. A clinicopathological study of seven globes enucleated after primary radiation therapy for malignant melanoma of the choroid or ciliary body. Can J Ophthalmol 25 (1990) 340-344
3. Messmer E., Bornfeld N., Foerster M., et al. Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma. Graefes Arch Clin Exp Ophthalmol 230 (1992) 391-396
4. Schilling H., Sehu K.W., and Lee W.R. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques. Invest Ophthalmol Vis Sci 38 (1997) 2081-2092
5. Toivonen P., Mäkitie T., Kujala E., and Kivelä T. Macrophages and microcirculation in regressed and partially regressed irradiated choroidal and ciliary body melanomas. Curr Eye Res 27 (2003) 237-245
6. Manschot W.A., and van Strik R. Uveal melanoma. therapeutic consequences of doubling times and irradiation results. A review. Int Ophthalmol 16 (1992) 91-99
7. Seregard S., Lundell G., Lax I., et al. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma. Acta Ophthalmol Scand 75 (1997) 148-154
8. Pe'er J., Stefani F.H., Seregard S., et al. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy. an EORTC Ocular Oncology Group study. Br J Ophthalmol 85 (2001) 1208-1212
9. Mäkitie T., Summanen P., Tarkkanen A., and Kivelä T. Tumor-infiltrating macrophages (CD68+ cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci 42 (2001) 1414-1421
10. Clarijs R., Schalkwijk L., Ruiter D.J., and de Waal R.M. EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma. Invest Ophthalmol Vis Sci 44 (2003) 1801-1806
11. Bingle L., Brown N.J., and Lewis C.E. The role of tumour-associated macrophages in tumour progression. implications for new anticancer therapies. J Pathol 196 (2002) 254-265
12. Scholes A.G., Hagan S., Hiscott P., et al. Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma. Arch Ophthalmol 119 (2001) 373-377
13. Sunderkötter C., Steinbrink K., Goebeler M., et al. Macrophages and angiogenesis. J Leukoc Biol 55 (1994) 410-422
14. Kerkelä E., Ala-Aho R., Jeskanen L., et al. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol 114 (2000) 1113-1119
15. Chen J.J., Lin Y.C., Yao P.L., et al. Tumor-associated macrophages. the double-edged sword in cancer progression. J Clin Oncol 23 (2005) 953-964
16. Wilbanks G.A., and Streilein J.W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral-blood. J Immunol 146 (1991) 2610-2617
17. Streilein J.W., Wilbanks G.A., Taylor A., and Cousins S. Eye-derived cytokines and the immunosuppressive intraocular microenvironment. a review. Curr Eye Res 11 suppl (1992) 41-47
18. Heikkonen J., Summanen P., Immonen I., et al. Radiotherapy of malignant melanoma of the uvea with I-125 seeds. Acta Ophthalmol (Copenh) 70 (1992) 780-785
19. Richtig E., Langmann G., Müllner K., et al. Calculated tumour volume as a prognostic parameter for survival in choroidal melanomas. Eye 18 (2004) 619-623
20. Fuchs U., Kivelä T., Summanen P., et al. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma. Am J Pathol 141 (1992) 169-181
21. Burnier Jr. M.N., McLean I.W., and Gamel J.W. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase. Cancer 68 (1991) 809-814
22. Steuhl K.P., Rohrbach J.M., Knorr M., and Thiel H.J. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors. Ophthalmology 100 (1993) 208-215
23. Kivelä T. Immunohistochemical staining followed by bleaching of melanin. a practical method for ophthalmic pathology. [letter]. Br J Biomed Sci 52 (1995) 325-326
24. Puusaari I., Heikkonen J., Summanen P., et al. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Ophthalmology 110 (2003) 2223-2234
25. Hair Jr. J.F., Tatham R.L., Anderson R.E., and Black W.C. Multivariate Data Analysis. 5th ed. (1998), Prentice-Hall, Upper Saddle River, NJ
26. Kleinbaum D.G. Logistic Regression. A Self-Learning Text (1994), Springer, New York
27. Parmar M.K.B., and Machin D. Survival Analysis. A Practical Approach (1995), Wiley, Chichester, United Kingdom 1-51
28. Machin D., Campbell M.J., Fayers P.M., and Pinol A.P.Y. Sample Size Tables for Clinical Studies. 2nd ed. (1997), Blackwell, Oxford, United Kingdom 218-235
29. Schmollinger J.C., and Dranoff G. Targeting melanoma inhibitor of apoptosis protein with cancer immunotherapy. Apoptosis 9 (2004) 309-313